心臓バイオマーカーの世界市場

◆英語タイトル:Global Cardiac Biomarkers Market 2017-2021
◆商品コード:IRTNTR14643
◆発行会社(リサーチ会社):Technavio
◆発行日:2017年10月10日
◆ページ数:96
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥385,000見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥550,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Technavio社の概要及び新刊レポートはこちらでご確認いただけます。

Technavio社が発行した当調査レポートでは、心臓バイオマーカーの世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、心臓バイオマーカーの世界市場規模及び予測、技術別分析、製品別分析、需要先別分析、地域別分析/市場規模、購買基準、市場の成長要因、市場の課題、市場動向、競争状況などの情報をお届けいたします。Technavio社は心臓バイオマーカーの世界市場が2017-2021年期間中に年平均12.97%成長すると予測しています。当レポート上に記載されている主な企業は、Abbott、Alere、F. Hoffmann-La Roche等です。

・エグゼクティブサマリー
・心臓バイオマーカーの世界市場:市場概観
・心臓バイオマーカーの世界市場:業界の構造分析
・心臓バイオマーカーの世界市場:市場規模及び予測
・心臓バイオマーカーの世界市場:技術別分析
・心臓バイオマーカーの世界市場:製品別分析
・心臓バイオマーカーの世界市場:需要先別分析
・心臓バイオマーカーの世界市場:地域別分析
・心臓バイオマーカーの世界市場:アジア市場規模
・心臓バイオマーカーの世界市場:アメリカ市場規模
・心臓バイオマーカーの世界市場:ヨーロッパ市場規模
・心臓バイオマーカーの世界市場:成長要因
・心臓バイオマーカーの世界市場:課題
・心臓バイオマーカーの世界市場:購買基準
・心臓バイオマーカーの世界市場:市場動向
・心臓バイオマーカーの世界市場:競争状況
...

※上記の和訳は最新内容ではない場合があります。
【レポートの概要】

About Cardiac Biomarkers
Cardiac biomarkers are the substances used to detect the risk stratification of a patient with chest pain or suspected acute coronary syndrome (ACS). These biomarkers are released in blood when the heart is damaged or stressed. The tests that are carried out by introducing the cardiac biomarkers to the bloodstream help in determining the risks of associated heart conditions such as cardiac ischemia, ACS, myocardial infarction, and other associated heart diseases.

Technavio’s analysts forecast the global cardiac biomarkers market to grow at a CAGR of 12.97% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global cardiac biomarkers market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Cardiac Biomarkers Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Abbott
• Alere
• F. Hoffmann-La Roche

[Other prominent vendors]
• Advanced ImmunoChemical
• AgPlus Diagnostics
• AZSense
• BD
• BG Medicine
• BioLegend
• bioMérieux
• Bio-Rad Laboratories
• BODITECH MED
• CAVADIS
• Cisbio Bioassays
• Creative Diagnostics
• Critical Diagnostics
• Cruinn Medical
• DiaDexus
• Enzo Life Sciences
• Lepu Medical
• LifeSign
• LSI Medience
• Merck
• Monobind
• Myriad RBM
• NeoClone
• NOWDiagnostics
• Olink
• Randox Laboratories
• Response Biomedical
• Signosis
• Thermo Fisher Scientific
• Tosoh Europe
• Trinity Biotech
• Trivitron Healthcare
• Wondfo

[Market driver]
• Increasing use of cardiac biomarkers
• For a full, detailed list, view our report

[Market challenge]
• Dominance of top vendors
• For a full, detailed list, view our report

[Market trend]
• Increased clinical trials
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

Table of Contents
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
• Market outline

PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 06: Market segmentation by technology
• Market overview
• Conventional laboratory testing
• POC testing

PART 07: Market segmentation by product
• Market overview
• Global troponin (cTnI, cTnT) assay market
• Global others assay market
• Global BNP & NT-proBNP assay market
• Global CK-MB assay market
• Global myoglobin assay market

PART 08: Market segmentation by end-user
• Market overview
• Hospitals and clinics
• Diagnostic laboratories

PART 09: Geographical segmentation
• Market overview
• Cardiac biomarkers market in Americas
• Cardiac biomarkers market in EMEA
• Cardiac biomarkers market in APAC

PART 10: Decision framework

PART 11: Drivers and challenges
• Market drivers
• Market challenges

PART 12: Market trends
• Increased clinical trials
• Increasing use of cardiac biomarkers in POC testing
• Emerging cardiac biomarkers

PART 13: Vendor landscape
• Competitive landscape
• Abbott
• Alere
• F. Hoffmann-La Roche
• Key companies to watch
• Other prominent vendors

PART 14: Appendix
• List of abbreviations

[List of Exhibits] Exhibit 01: Advantages associated with cardiac biomarkers
Exhibit 02: Market overview of global cardiac biomarkers market 2016
Exhibit 03: Global cardiac biomarkers market 2016-2021 ($ millions)
Exhibit 04: Five forces analysis
Exhibit 05: Overview of global cardiac biomarkers market by technology 2016
Exhibit 06: Global cardiac biomarkers market by conventional laboratory testing 2016-2021 ($ millions)
Exhibit 07: Global cardiac biomarkers market by POC testing 2016-2021 ($ millions)
Exhibit 08: Overview of global cardiac biomarkers market by product 2016
Exhibit 09: Global troponin (cTnI, cTnT) assay market 2016-2021 ($ millions)
Exhibit 10: Global others assay market 2016-2021 ($ millions)
Exhibit 11: Global BNP & NT-proBNP assay market 2016-2021 ($ millions)
Exhibit 12: Global CK-MB assay market 2016-2021 ($ millions)
Exhibit 13: Global myoglobin assay market 2016-2021 ($ millions)
Exhibit 14: Overview and strategy of global cardiac biomarkers market by end-users 2016
Exhibit 15: Buying criteria of end-users in global cardiac biomarkers market 2016
Exhibit 16: Global cardiac biomarkers market by geography 2016 and 2021
Exhibit 17: Overview of cardiac biomarkers market in Americas
Exhibit 18: Cardiac biomarkers market in Americas 2016-2021 ($ millions)
Exhibit 19: Overview of cardiac biomarkers market in EMEA
Exhibit 20: Cardiac biomarkers market in EMEA 2016-2021 ($ millions)
Exhibit 21: Overview of cardiac biomarkers market in APAC
Exhibit 22: Cardiac biomarkers market in APAC 2016-2021 ($ millions)
Exhibit 23: Market analysis for the increasing cardiac diseases worldwide
Exhibit 24: Average cost of cardiac biomarkers
Exhibit 25: Clinical trials and their impact
Exhibit 26: Competitive structure analysis of global cardiac biomarkers market 2016
Exhibit 27: Market penetration of various cardiac biomarkers providers 2016
Exhibit 28: Strategic success factors of companies in global cardiac biomarkers market 2016
Exhibit 29: Abbott: Strength assessment
Exhibit 30: Abbott: Strategy assessment
Exhibit 31: Abbott: Opportunity assessment
Exhibit 32: Alere: Strength assessment
Exhibit 33: Alere: Strategy assessment
Exhibit 34: Alere: Opportunity assessment
Exhibit 35: F. Hoffmann-La Roche: Strength assessment
Exhibit 36: F. Hoffmann-La Roche: Strategy assessment
Exhibit 37: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 38: Danaher: Company assessment
Exhibit 39: Siemens: Company assessment



【掲載企業】

Abbott, Alere, F. Hoffmann-La Roche, Advanced ImmunoChemical, AgPlus Diagnostics, AZSense, BD, BG Medicine, BioLegend, bioMérieux, Bio-Rad Laboratories, BODITECH MED, CAVADIS, Cisbio Bioassays, Creative Diagnostics, Critical Diagnostics, Cruinn Medical, DiaDexus, Enzo Life Sciences, Lepu Medical, LifeSign, LSI Medience, Merck, Monobind, Myriad RBM, NeoClone, NOWDiagnostics, Olink, Randox Laboratories, Response Biomedical, Signosis, Thermo Fisher Scientific, Tosoh Europe, Trinity Biotech, Trivitron Healthcare, and Wondfo.

【レポートのキーワード】

心臓バイオマーカー

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 心臓バイオマーカーの世界市場(Global Cardiac Biomarkers Market 2017-2021)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆